MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/20.06.25 Share Price

Warrant

DE000MB5S4X6

Market Closed - Börse Stuttgart 20:00:10 09/05/2024 BST
0.051 EUR -7.27% Intraday chart for MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/20.06.25
Current month-17.74%
1 month-49.50%
Date Price Change Volume
09/05/24 0.051 -7.27% 0
08/05/24 0.055 -8.33% 0
07/05/24 0.06 +5.26% 0
06/05/24 0.057 -12.31% 0
03/05/24 0.065 +6.56% 0

Delayed Quote Börse Stuttgart

Last update May 09, 2024 at 08:00 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB5S4X
ISINDE000MB5S4X6
Date issued 21/04/2023
Strike 160 $
Maturity 20/06/2025 (407 Days)
Parity 10 : 1
Emission price 0.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.34
Lowest since issue 0.049
Spread 0.004
Spread %7.27%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.9 USD
Average target price
126.1 USD
Spread / Average Target
+20.20%
Consensus